179 related articles for article (PubMed ID: 31562178)
21. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
Chen RZ; Akbarian S; Tudor M; Jaenisch R
Nat Genet; 2001 Mar; 27(3):327-31. PubMed ID: 11242118
[TBL] [Abstract][Full Text] [Related]
22. Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome.
Robinson L; Guy J; McKay L; Brockett E; Spike RC; Selfridge J; De Sousa D; Merusi C; Riedel G; Bird A; Cobb SR
Brain; 2012 Sep; 135(Pt 9):2699-710. PubMed ID: 22525157
[TBL] [Abstract][Full Text] [Related]
23. The role of MeCP2 in CNS development and function.
Na ES; Monteggia LM
Horm Behav; 2011 Mar; 59(3):364-8. PubMed ID: 20515694
[TBL] [Abstract][Full Text] [Related]
24. Excitatory synapses are stronger in the hippocampus of Rett syndrome mice due to altered synaptic trafficking of AMPA-type glutamate receptors.
Li W; Xu X; Pozzo-Miller L
Proc Natl Acad Sci U S A; 2016 Mar; 113(11):E1575-84. PubMed ID: 26929363
[TBL] [Abstract][Full Text] [Related]
25. MECP2 disorders: from the clinic to mice and back.
Lombardi LM; Baker SA; Zoghbi HY
J Clin Invest; 2015 Aug; 125(8):2914-23. PubMed ID: 26237041
[TBL] [Abstract][Full Text] [Related]
26. Correcting deregulated Fxyd1 expression rescues deficits in neuronal arborization and potassium homeostasis in MeCP2 deficient male mice.
Matagne V; Wondolowski J; Frerking M; Shahidullah M; Delamere NA; Sandau US; Budden S; Ojeda SR
Brain Res; 2018 Oct; 1697():45-52. PubMed ID: 29902467
[TBL] [Abstract][Full Text] [Related]
27. MeCP2 deficiency impairs motor cortical circuit flexibility associated with motor learning.
Yue Y; Ash RT; Boyle N; Kinter A; Li Y; Zeng C; Lu H
Mol Brain; 2022 Sep; 15(1):76. PubMed ID: 36064580
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis of lethal cardiac arrhythmias in Mecp2 mutant mice: implication for therapy in Rett syndrome.
McCauley MD; Wang T; Mike E; Herrera J; Beavers DL; Huang TW; Ward CS; Skinner S; Percy AK; Glaze DG; Wehrens XH; Neul JL
Sci Transl Med; 2011 Dec; 3(113):113ra125. PubMed ID: 22174313
[TBL] [Abstract][Full Text] [Related]
29. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.
Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V
BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734
[TBL] [Abstract][Full Text] [Related]
30. Deleting
Achilly NP; He LJ; Kim OA; Ohmae S; Wojaczynski GJ; Lin T; Sillitoe RV; Medina JF; Zoghbi HY
Elife; 2021 Jan; 10():. PubMed ID: 33494858
[TBL] [Abstract][Full Text] [Related]
31. Graded and pan-neural disease phenotypes of Rett Syndrome linked with dosage of functional MeCP2.
Chen X; Han X; Blanchi B; Guan W; Ge W; Yu YC; Sun YE
Protein Cell; 2021 Aug; 12(8):639-652. PubMed ID: 32851591
[TBL] [Abstract][Full Text] [Related]
32. Radically truncated MeCP2 rescues Rett syndrome-like neurological defects.
Tillotson R; Selfridge J; Koerner MV; Gadalla KKE; Guy J; De Sousa D; Hector RD; Cobb SR; Bird A
Nature; 2017 Oct; 550(7676):398-401. PubMed ID: 29019980
[TBL] [Abstract][Full Text] [Related]
33. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.
Chang Q; Khare G; Dani V; Nelson S; Jaenisch R
Neuron; 2006 Feb; 49(3):341-8. PubMed ID: 16446138
[TBL] [Abstract][Full Text] [Related]
34. Disease modeling using embryonic stem cells: MeCP2 regulates nuclear size and RNA synthesis in neurons.
Yazdani M; Deogracias R; Guy J; Poot RA; Bird A; Barde YA
Stem Cells; 2012 Oct; 30(10):2128-39. PubMed ID: 22865604
[TBL] [Abstract][Full Text] [Related]
35. A codon-optimized Mecp2 transgene corrects breathing deficits and improves survival in a mouse model of Rett syndrome.
Matagne V; Ehinger Y; Saidi L; Borges-Correia A; Barkats M; Bartoli M; Villard L; Roux JC
Neurobiol Dis; 2017 Mar; 99():1-11. PubMed ID: 27974239
[TBL] [Abstract][Full Text] [Related]
36. Vitamin D modulates cortical transcriptome and behavioral phenotypes in an Mecp2 heterozygous Rett syndrome mouse model.
Ribeiro MC; MacDonald JL
Neurobiol Dis; 2022 Apr; 165():105636. PubMed ID: 35091041
[TBL] [Abstract][Full Text] [Related]
37. Developmental abnormalities of cortical interneurons precede symptoms onset in a mouse model of Rett syndrome.
Tomassy GS; Morello N; Calcagno E; Giustetto M
J Neurochem; 2014 Oct; 131(1):115-27. PubMed ID: 24978323
[TBL] [Abstract][Full Text] [Related]
38. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
39. Developmental loss of MeCP2 from VIP interneurons impairs cortical function and behavior.
Mossner JM; Batista-Brito R; Pant R; Cardin JA
Elife; 2020 Apr; 9():. PubMed ID: 32343226
[TBL] [Abstract][Full Text] [Related]
40. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]